numares Novel GFR Equation Allows Accurate Assessment of Renal Insufficiency in Proof of Concept finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics
numares AG and analytical instrumentation and solution provider
Bruker Corporation have signed an agreement to collaborate to bring new diagnostics tests utilizing NMR to the laboratory market for unmet medical needs. The tests are based on the automated measurement of metabolites using a strong magnet field, and artificial intelligence. The platform is marketed under the
numares brand
AXINON
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005438/en/
numare s AI-driven, NMR-based diagnostic platform AXINON is easy to operate by laboratory technicians. (Photo: Business Wire)
numares Novel Multi-marker Kidney Function Testing Shows Promising Results in US Validation Study
numares successfully finished validation of a multi-marker serum test of kidney function
GFR
NMRuses a defined model for glomerular filtration rate (GFR) equation to assess kidney function, comprised of the analysis of several metabolites in serum together with age and sex.
numares today announced that its novel multi-marker approach for the accurate assessment of glomerular filtration rate (GFR) shows promising results in a US based clinical validation study. Using serum,
GFRNMR evaluates a metabolite constellation of three metabolites combined with Cystatin C, age and sex. Compared to existing serum-based GFR methods, this multi-marker algorithm more accurately reflects gold-standard invasive clearance testing methods.